Skip to content
- Home
- Pharmaceutical
- AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan
AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan – Express Pharma
Source link